These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37862797)

  • 41. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
    Song BG; Park JK; Kim HS; Kim K; Park JK; Lee KH; Lee KT; Lee JK
    Scand J Gastroenterol; 2019 Jun; 54(6):740-745. PubMed ID: 31136212
    [No Abstract]   [Full Text] [Related]  

  • 42. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis.
    Xian F; Ren D; Bie J; Xu G
    Front Immunol; 2023; 14():1119168. PubMed ID: 37138876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dong Z; Liao B; Shen W; Sui C; Yang J
    Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses.
    Yoon JG; Kim MH; Jang M; Kim H; Hwang HK; Kang CM; Lee WJ; Kang B; Lee CK; Lee MG; Chung HC; Choi HJ; Park YN
    Hepatology; 2021 Oct; 74(4):1914-1931. PubMed ID: 33884649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
    Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
    J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Programmed death 1 monoclonal antibody helped to treat mixed chimeric and reactivation of Epstein-Barr virus in a patient with adult-onset chronic active Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation: A case report.
    You Y; Wang J; Wang Z
    Medicine (Baltimore); 2022 Jan; 101(2):e28542. PubMed ID: 35029211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component.
    Chen TC; Ng KF; Kuo T
    Mod Pathol; 2001 May; 14(5):527-32. PubMed ID: 11353065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphoepithelioma-like cholangiocarcinoma not associated with Epstein-Barr virus.
    Hur YH; Kim HH; Koh YS; Seoung JS; Cho CK
    ANZ J Surg; 2011 Sep; 81(9):652-3. PubMed ID: 22295412
    [No Abstract]   [Full Text] [Related]  

  • 49. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential missed opportunities for diagnosis of lymphoepithelioma-like intrahepatic cholangiocarcinoma: report of a rare case.
    Tang W; Huang Y; Yu S; Wang T; Yang J; Zhao Z
    J Int Med Res; 2023 Nov; 51(11):3000605231210174. PubMed ID: 37994034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein-Barr virus: Two cases report.
    Ling W; Lu C; Huang H; Qiu T; Lu Q; Huang C; Gong P; Luo Y; Chen S
    Medicine (Baltimore); 2019 Jan; 98(3):e14206. PubMed ID: 30653176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti-PD-1 immunotherapy for unresectable intrahepatic cholangiocarcinoma.
    Zhang N; Yu BR; Wang YX; Zhao YM; Zhou JM; Wang M; Wang LR; Lin ZH; Zhang T; Wang L
    J Dig Dis; 2022 Aug; 23(8-9):535-545. PubMed ID: 36148493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphoepithelioma-like cholangiocarcinoma not associated with EBV.
    Adachi S; Morimoto O; Kobayashi T
    Pathol Int; 2008 Jan; 58(1):69-74. PubMed ID: 18067645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hidden Carcinoma: Pitfalls in the Diagnosis of Lymphoepithelioma-Like Cholangiocarcinoma.
    Mostyka M; Birch MM; Samstein B; Pittman ME
    Int J Surg Pathol; 2020 Dec; 28(8):872-878. PubMed ID: 32429781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphoepithelioma-like neoplasm of the biliary tract with 'probable low malignant potential'.
    Khandakar B; Liu JR; Thung S; Li Y; Rhee H; Kagen AC; Sun-Wing Tong T; Nyun Park Y; Theise N; Oi-Lin Ng I
    Histopathology; 2022 Mar; 80(4):720-728. PubMed ID: 34608670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer.
    Wei XL; Liu QW; Liu FR; Yuan SS; Li XF; Li JN; Yang AL; Ling YH
    Oncoimmunology; 2021; 10(1):1938381. PubMed ID: 34235004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer.
    Kim H; Kim J; Byeon S; Jang KT; Hong JY; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK; Kim ST
    Oncology; 2021; 99(6):365-372. PubMed ID: 33730723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR
    JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Carcinoma with predominant lymphoid stroma in hepatobiliary system--report of 2 cases].
    Min HS; Shin E; Jang JJ
    Korean J Hepatol; 2007 Jun; 13(2):222-7. PubMed ID: 17585195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis.
    Ma Y; Zhang P; Bao Y; Luo H; Wang J; Huang L; Zheng M
    Front Immunol; 2023; 14():1093719. PubMed ID: 36969150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.